Updated on 4 September 2026
Preclinical Research and Development of Novel Anticancer Therapeutics
Associate professor, Head of the Department at Faculty of Pharmacy, Comenius University Bratislava
Bratislava, Slovakia
About
Research groups at the Faculty of Pharmacy, Comenius University Bratislava, offer complementary expertise covering multiple stages of the preclinical drug discovery and development process, from rational drug design and computational modelling to synthesis, formulation, and pharmacological evaluation of promising drug candidates.
Our expertise and research capabilities include:
-
rational drug design and molecular modelling;
-
quantitative structure–activity relationship (QSAR) studies;
-
virtual combinatorial library design and in silico screening;
-
ADME/Tox prediction and profiling;
-
structure-based drug design and lead optimization;
-
synthesis and characterization of promising drug candidates;
-
in vitro screening and biological evaluation;
-
development of drug delivery systems and carriers;
-
pharmaceutical formulation and drug delivery;
-
pharmacological evaluation of novel drug candidates.
These capabilities can be combined according to the specific needs of a collaborative project, enabling our research teams to contribute to different stages of the preclinical development of novel anticancer therapeutics.
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Preclinical Research and Development of Novel Anticancer Therapeutics
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Vladimir Frecer
Professor, vice dean for research activities, foreign relations, and projects at Faculty of Pharmacy, Comenius University Bratislava
Bratislava, Slovakia
Project cooperation
Nanomedicine for Drug Delivery, Imaging and Theranostics
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
Brindusa Dragoi
Senior Scientist at Regional Institute of Oncology, Iasi
Iasi, Romania
Project cooperation
PRO-DEPEND: Functional Genomics of Prostate Cancer Vulnerabilities
- Consortium/Coordinator seeks Partners
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Magdalena Krystkiewicz-Orzechowska
Assistant Professor at Department of Molecular Carcinogenesis, Medical University of Łódź
Łódź, Poland